You know, all of my adult life, I've been a hard-hitting fiscal conservative.
If you'd come to me two or three years ago and said there's a new government mandate - a California government mandate - that Michael Robinson was going to love and endorse, I would've laughed you out of the room.
But, my new research has completely shifted my stance.
You know, all of my adult life, I've been a hard-hitting fiscal conservative.
If you'd come to me two or three years ago and said there's a new government mandate - a California government mandate - that Michael Robinson was going to love and endorse, I would've laughed you out of the room.
But, my new research has completely shifted my stance.
I recently got the kind of news that no child wants to hear about an aging parent.
Here's the thing: I count my blessings that my dad lived so long. After all, he's a retired Marine Corps captain who saw three tours of combat, one in Korea and two in Vietnam.
Honestly, he's lucky he lived as long as he did. But that still doesn't make the aging process any easier, at least not on the body.
He recently had a second knee replacement that didn't go as well as planned. He also has swelling of the feet. His mobility is not all that great, and he can't drive right now.
At 86, he recently learned he has congestive heart failure. That's a condition in which the heart doesn't pump as strongly as it should, leading to a buildup of fluids.
As such, my dad is part of a huge trend in America. Fact is, according to the American Heart Association, cardiovascular disease is set to have an economic impact of $1.1 trillion by 2035.
And today, I want to reveal a life sciences firm that is bringing badly needed relief to millions of heart patients - and show you five reasons why it's set to double in as little as three-and-a-half years...
Like many holidays, Singles Day in China has morphed into a massive moment of commerce heavily promoted by Alibaba Group Holding Ltd. (NASDAQ: BABA).
In fact, it’s become the biggest shopping day in the world. The 2019 version of Singles Day was another record breaker. In 24 hours, more than $38 billion was spent over Alibaba’s network of e-commerce sites.
And the massive amount of money spent on Singles Day is just one of dozens of reasons to buy Alibaba stock despite its high price tag…
You could forgive drug and biotech executives for having a bad case of target fixation.
After all, they do work in a field that is filled with time-consuming and expensive headaches.
Consider that the Biotechnology Innovation Organization (BIO), the world's largest biotech trade organization, looked at 7,400 drug programs by 1,103 companies. They were investigating drug-approval rates.
The news was not good -just 9.6% of drugs scientists discover ever get approved for sale. That's a one-in-ten shot.
With such daunting data, it's no wonder that, even in a field already worth $1.2 trillion in global sales, industry leaders are on the lookout for ways to lower the cost of discovery and shorten time to market.
And with that goal in mind, I've uncovered a high-octane, large-cap firm that has become an essential ingredient in the drug sector's success.
It's a cloud-based leader in pharmaceutical efficiency that has a history of crushing the market by no small measure.
And it's been doubling its earnings, on average, every 18 months...
I must be throwing off a strong "dad vibe" these days. And that's got me thinking maybe my chance conversations with a number of young adults lately is a sign of the times.
As I've been going about my daily routines, I've run into a lot of young adults my daughters' age who want to get invested but have no clue how to do so. They have income, but they don't know where to start.
For instance, once, while skiing at the Kirkwood Mountain Resort near Lake Tahoe, I chatted with three young adults who jumped at the chance to get my advice about investing.
I told them about a surefire way to make the market work for them as though I were talking to my own daughters.
I'll share it with everyone today - this strategy is good for new investors and old pros, and it's particularly effective for folks who've been reluctant to jump in to such a volatile market.
I'll name a "starter" investment, of course - one I always recommend for young folks to get them on the right track - plus three other tech-centric ways to jumpstart your investing today.
This publicity stunt at MetLife Stadium in New Jersey just signaled how powerful 5G stocks are.
Amazon just bought 100,000 electric trucks from Rivian.
This is a massive boon for electric vehicle stocks.
Here’s whether you can buy Rivian stock.
For the past 54 years, tech stocks have beaten the broader market when recession signals start to flash red. And this time, it’s no different.
Check out the best tech stocks to buy to ride this market turbulence.
For the first time since 2007, the two-year and 10-year treasury yields have inverted.
But despite fears of a recession, tech stocks have a long history of outperforming the market during a yield-curve inversion.
2019 has been a bigger year for clean energy.
And to help you capitalize on its $10 trillion opportunity, here are the best renewable energy stocks to buy now.
My wife says that at the rate I'm going, we're going to have to buy a new table.
Let me explain. My job as your tech analyst is to go beyond the headlines and find great tech stocks that can absolutely crush the market - in good times and in bad.
And that often means pounding the table for the global tech ecosystem in general, and for market rippers in particular.
That's exactly what I did back on Jan. 11. You may not recall it, but in my mind's eye, it's as if it were just yesterday.
At the time, the tech-centric Nasdaq had entered bear market territory, defined as a 20% drop from a recent high. I said it was "fear and not fundamentals" that was driving the market lower.
I then listed three beaten-down tech leaders I said were poised for big rebounds.
Today, I'm following up let you know - all three just crushed it, as I'll show you.
And I'll also show you why there's still plenty of upside ahead...
By now, I think it's safe to say that Jim Cramer was dead wrong.
And I was right on the money.
Here's the thing. I remember very clearly the day that Amazon.com Inc. (AMZN) crossed the $1,000 mark on May 31, 2017.
Cramer, the host of CNBC's Mad Money looked at the price and slammed it. He said that "psychologically" $1,000 is a lot to pay for a stock he felt was getting ahead of itself.
As the saying goes, that was then and this is now.
No doubt, the tech leader hit a rough patch late last year with the rest of the market. And it has come under fire recently as part of the Big Tech backlash.
Yet, as the firm prepares to report earnings later this week, the stock is once again trading in the $2,000 range, double what Cramer was worrying about.
Not only that, but the "King of E-commerce" is just shy of hitting another historic moment. It's roughly 2% from having a $1 trillion market cap.
And today, I'm going to show you why I still firmly believe the stock will hit at least $3,000 a share - and likely much, much more than that...
I don't know about you, but I would love to own a piece of the Fast & Furious movie franchise.
I recently saw a preview for the ninth installment set to debut in the spring of 2020. I'm a big fan of the action-adventure genre in general, and this series of movies in particular.
It features a group of misfits who transform from street racing hot rods to become an international espionage team.
Don't scoff, there's big money here. To date, the nine movies have brought in more than $5 billion.
Here's the thing. Something similar is happening in the high-margin software sector.
Technically speaking, it's a field known as "DevOps." The term refers to the $50 billion up for grabs by helping companies make a transition from legacy systems to cutting-edge digital tech.
Today, I'm going to show you what I call 'Software's Fast & Furious.
And I'll reveal a company that will more than double the market's return for years to come...
These days just about every sane American is in love with Wall Street.
In fact, I haven't seen the Street get so much positive publicity in many years.
And it's easy to see why. All three major indexes posted massive gains for the first half of the year, tying decades-old records on the strength of June's rally.
Consider that the S&P 500 had its best June since 1955 as the Dow logged its best performance since 1938. The tech-centric Nasdaq had its best June since 2000.
So, you might be tempted to think all you had to do was throw a dart at the stock tables to find a winner.
Truth be told, you can do far better - if you have a savvy tech expert carefully hand selecting stocks for you.
Just ask the readers of my Nova-X Report. They had four stocks that gained 100% each through the end of June.
Today, I'm going to show you how we did it, and how you can get in on the sizzling action here...
It's time for me to update the mantra I have used here for many years.
No, I haven't backed off my belief that the road to wealth is paved with tech.
Just the opposite in fact. What's really going on these days is that the road to wealth is becoming a super highway.
Let me explain. As I have noted many times in our twice-weekly chats, U.S. tech firms generate enormous amounts of cash.
That's one of the reasons why the top four American tech firms have combined market caps of $3.6 trillion, or roughly the size of Canada and Brazil's economies combined.
Indeed, their profit margins are so huge they simply can't invest it all in the next round of innovation.
And it explains why tech firms are the leaders in one of the market's more important new dynamics - share buybacks.
Don't underestimate the importance of this red-hot new trend. Just in the first quarter, we're talking at least $126 billion of tech share purchases.
Today, I'm going to reveal a great way to play this trend. And it's with an investment that has beaten the broad market by 161%...
